Cargando…

Circulating Tumor Cells (CTCs): A Unique Model of Cancer Metastases and Non-invasive Biomarkers of Therapeutic Response

Late-stage cancer metastasis remains incurable in the clinic and is the major cause death in patients. Circulating tumor cells (CTCs) are thought to be metastatic precursors shed from the primary tumor or metastatic deposits and circulate in the blood. The molecular network regulating CTC survival,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Jialing, Lian, Jingru, Chen, Yafei, Zhao, Xin, Du, ChangZheng, Xu, Yang, Hu, Hailiang, Rao, Hai, Hong, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424190/ https://www.ncbi.nlm.nih.gov/pubmed/34512735 http://dx.doi.org/10.3389/fgene.2021.734595

Ejemplares similares

The propensity of invasive circulating tumor cells (iCTCs) in metastatic progression and therapeutic responsiveness
por: Dong, Huan, et al.
Publicado: (2019)

Molecular Profiling of Benign Metastasizing Leiomyoma of the Uterus Revealing Unique Novel Therapeutic Targets
por: Findakly, Dawood, et al.
Publicado: (2020)

Circulating tumor cells (CTCs) and hTERT gene expression in CTCs for radiotherapy effect with lung cancer
por: Xu, Ying, et al.
Publicado: (2023)

Liquid Biopsy in Lung Cancer: Clinical Applications of Circulating Biomarkers (CTCs and ctDNA)
por: Lim, Minji, et al.
Publicado: (2018)

Ex vivo expansion of circulating tumour cells (CTCs)
por: Mohamed, Bashir M., et al.
Publicado: (2023)

Circulating MicroRNAs as Minimally Invasive Biomarkers for Cancer Theragnosis and Prognosis
por: Cho, William C. S.
Publicado: (2011)

Apoptotic circulating tumor cells (CTCs) in the peripheral blood of metastatic colorectal cancer patients are associated with liver metastasis but not CTCs
por: Allen, Joshua E., et al.
Publicado: (2013)

The Prognostic Role of Circulating Tumor Cells (CTCs) in Lung Cancer
por: Kapeleris, Joanna, et al.
Publicado: (2018)

Fugitives on the run: circulating tumor cells (CTCs) in metastatic diseases
por: Mamdouhi, Tania, et al.
Publicado: (2019)

Potential Use of CTCs as Biomarkers in Renal Cancer Patients
por: Bialek, Joanna, et al.
Publicado: (2022)

Gauging the Impact of Cancer Treatment Modalities on Circulating Tumor Cells (CTCs)
por: Mathias, Trevor J., et al.
Publicado: (2020)

The Mechanical Fingerprint of Circulating Tumor Cells (CTCs) in Breast Cancer Patients
por: Nel, Ivonne, et al.
Publicado: (2021)

Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design
por: Kejík, Zdeněk, et al.
Publicado: (2021)

Are Circulating Tumor Cells (CTCs) Ready for Clinical Use in Breast Cancer? An Overview of Completed and Ongoing Trials Using CTCs for Clinical Treatment Decisions
por: Schochter, Fabienne, et al.
Publicado: (2019)

Maternal Circulating Exosomal miRNAs as Non-invasive Biomarkers for the Prediction of Fetal Ventricular Septal Defect
por: Jin, Yuxia, et al.
Publicado: (2021)

Circulating microRNA: Myocardium-derived prenatal biomarker of ventricular septal defects
por: Yang, Yiru, et al.
Publicado: (2022)

Dangerous Liaisons: Circulating Tumor Cells (CTCs) and Cancer-Associated Fibroblasts (CAFs)
por: Hurtado, Pablo, et al.
Publicado: (2020)

Biosensors for the Isolation and Detection of Circulating Tumor Cells (CTCs) in Point-of-Care Settings
por: Goldstein, Isaac, et al.
Publicado: (2023)

Vimentin expression in circulating tumor cells (CTCs) associated with liver metastases predicts poor progression-free survival in patients with advanced lung cancer
por: Wang, Ying, et al.
Publicado: (2019)

Detection of CTCs in portal vein was associated with intrahepatic metastases and prognosis in patients with advanced pancreatic cancer
por: Liu, Xiaoyu, et al.
Publicado: (2018)

Serial Monitoring of Circulating Tumor DNA in Patients With Metastatic Colorectal Cancer to Predict the Therapeutic Response
por: Jia, Ning, et al.
Publicado: (2019)

Bioinformatics gene analysis of potential biomarkers and therapeutic targets of osteoarthritis associated myelodysplastic syndrome
por: Xin, Peicheng, et al.
Publicado: (2023)

Detection of circulating tumor cells (CTCs) in cerebrospinal fluid of a patient with HER2-overexpressing gastric cancer and single cell analysis of intra-patient heterogeneity of CTCs
por: Cho, Jang Ho, et al.
Publicado: (2019)

CTC-Derived Models: A Window into the Seeding Capacity of Circulating Tumor Cells (CTCs)
por: Tayoun, Tala, et al.
Publicado: (2019)

Circulating Cell-Free mtDNA Content as a Non-invasive Prognostic Biomarker in HCC Patients Receiving TACE and Traditional Chinese Medicine
por: Zhou, Guanlin, et al.
Publicado: (2021)

Transcriptional Analysis of Lennert Lymphoma Reveals a Unique Profile and Identifies Novel Therapeutic Targets
por: Etebari, Maryam, et al.
Publicado: (2019)

Immunomagnetic-Enriched Subpopulations of Melanoma Circulating Tumour Cells (CTCs) Exhibit Distinct Transcriptome Profiles
por: Aya-Bonilla, Carlos, et al.
Publicado: (2019)

Clinical Significance of Circulating Tumor Cells (CTCs) and Survivin on Predicting Prognosis in Thyroid Cancer Patients
por: Weng, Xun, et al.
Publicado: (2022)

A novel prognostic and therapeutic target biomarker based on necroptosis-related gene signature and immune microenvironment infiltration in gastric cancer
por: Xin, Dao, et al.
Publicado: (2022)

Circulating Cell-Free Nucleic Acids as Epigenetic Biomarkers in Precision Medicine
por: Rahat, Beenish, et al.
Publicado: (2020)

Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients
por: Anantharaman, Archana, et al.
Publicado: (2016)

Similarities and Differences of Photosynthesis Establishment Related mRNAs and Novel lncRNAs in Early Seedlings (Coleoptile/Cotyledon vs. True Leaf) of Rice and Arabidopsis
por: Shi, Yafei, et al.
Publicado: (2020)

Identification of Novel Biomarkers With Diagnostic Value and Immune Infiltration in Burn Injury
por: Zhou, Sitong, et al.
Publicado: (2022)

Blood Circulating miRNAs as Cancer Biomarkers for Diagnosis and Surgical Treatment Response
por: Filipów, Samantha, et al.
Publicado: (2019)

Identification of Serum Circulating MicroRNAs as Novel Diagnostic Biomarkers of Gastric Cancer
por: Yao, Yunjin, et al.
Publicado: (2021)

Circulating miR-26a as Potential Prognostic Biomarkers in Pediatric Rhabdomyosarcoma
por: Tombolan, Lucia, et al.
Publicado: (2020)

Circulating miRNAs in maternal plasma as potential biomarkers of early pregnancy in sheep
por: Hitit, Mustafa, et al.
Publicado: (2022)

Case Report: Prenatal diagnosis of fetal tetrasomy 9p initially identified by non-invasive prenatal testing
por: Yu, Jialing, et al.
Publicado: (2022)

A novel microchannel-based device to capture and analyze circulating tumor cells (CTCs) of breast cancer
por: RIAHI, REZA, et al.
Publicado: (2014)

Role of circulating tumour cells (CTCs) in recurrent/metastatic head and neck squamous cell carcinoma (HNSCC)
por: Baa, Annie Kanchan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_h13tp5hr8b8s5ps06gaf6d4htt